Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model

Tianbing Duan, Jin-Xia Zhang, Dingcheng Xiang, Rui Song, Ranran Kong, Dingli XuAdvances 2019 · DOI

Introduction

The Index of Coronary Microcirculatory Resistance (IMR) is a critical metric for assessing the health of the coronary microvasculature. Accurate IMR measurement requires the induction of "maximal hyperemia," a state where coronary vessels are fully dilated to achieve peak blood flow. While intracoronary (IC) papaverine has long been considered the "gold standard" for inducing this state in animal models, its clinical utility is hampered by a high incidence of arrhythmias. Alternatives like Adenosine Triphosphate (ATP) and nicorandil are used, but their optimal dosages for porcine models—which often require higher concentrations than humans—remain under-investigated. This study evaluates the effectiveness and safety of various dosages of papaverine, ATP, nicorandil, and alprostadil in a pig model.

Methods

The study utilized 28 pigs (average weight 21.2 kg). Researchers employed a pressure-temperature sensor guidewire in the left anterior descending (LAD) coronary artery to measure IMR, Fractional Flow Reserve (FFR), and Coronary Flow Reserve (CFR). Systemic hemodynamic parameters, including mean aortic pressure (Pa) and heart rate (HR), were monitored throughout.

The experimental design consisted of four protocols to compare the following IC bolus administrations:

  1. Papaverine (PAP): 18 mg (Control).
  2. ATP: Escalating doses of 40 μg, 80 μg, 160 μg, and 240 μg.
  3. Nicorandil (NCR): 2 mg and 4 mg doses.
  4. Alprostadil (ALP): 10 μg (Tested separately due to its long-lasting effects).
Experimental protocols for IMR measurement using different pharmacological agents.

Key Results

The study identified significant differences in both the efficacy and safety profiles of the tested agents.

Effectiveness in Inducing Hyperemia

Both 4 mg nicorandil and 240 μg ATP were found to be statistically equivalent to the 18 mg papaverine gold standard in achieving maximal hyperemia. Lower doses of ATP (40–160 μg) were insufficient to reach the same level of microvascular dilation. Conversely, while alprostadil is a potent vasodilator, it proved unsuitable for IMR measurement because it caused a prolonged (over 10 minutes) and massive (40%) drop in baseline blood pressure, destabilizing the physiological state required for accurate calculations.

Safety and Hemodynamic Stability

Nicorandil emerged as the most stable option. Compared to papaverine, which caused a mean aortic pressure drop (ΔPa) of 33 mmHg and a heart rate spike (ΔHR) of 38 bpm, 4 mg of nicorandil resulted in a significantly milder ΔPa of 19 mmHg and a ΔHR of 20 bpm. High-dose ATP (240 μg) also induced significant side effects, including tachypnea in 65% of subjects and transient ECG changes.

Comparison of heart rate changes (ΔHR) across different drug dosages, highlighting the lower impact of nicorandil compared to papaverine.

Discussion and Conclusion

The findings suggest that the standard clinical doses used in humans are often inadequate for achieving maximal hyperemia in porcine models. Specifically, 4 mg of nicorandil provides a highly effective and safer alternative to papaverine for IMR measurement in pigs, showing a strong linear correlation ($R^2 = 0.936$) with papaverine-derived IMR values while maintaining superior hemodynamic stability. While high-dose ATP is effective, its associated respiratory side effects make it a less ideal choice. Future research should investigate these responses in diseased (stenotic) models and explore the effects on the right coronary artery.

Summary updated

Abstract

Intracoronary bolus administration of 4 mg of nicorandil was better than 18 mg of papaverine or 240 μg of ATP for induction of maximal hyperemia and IMR measurement in a pig model, whereas alprostadil was not suitable for IMR measurement.
BibTeX
@inproceedings{duan2019effectiveness,
  author = {Tianbing Duan and Jin-Xia Zhang and Dingcheng Xiang and Rui Song and Ranran Kong and Dingli Xu},
  title = {{Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model}},
  booktitle = {Advances},
  year = {2019},
  doi = {10.17219/acem/104541},
}
Figure